Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...

Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...

The science of gene therapy is enjoying a renaissance after ups and downs over the past 25 years. The heart of this field still largely relies on viral vector gene transfer systems that have evolved ...

Introgen Therapeutic’s (Austin, TX) p53-based INGN 225 cancer vaccine yielded promising safety and efficacy results in a Phase II trial in advanced small cell lung cancer. The personalized therapeutic ...

IonQ said Wednesday the planned acquisition is intended to expand its quantum technology portfolio. By integrating Vector Atomic’s advanced PNT systems, including rackmount optical atomic clocks, ...

Artificial intelligence-driven search and discovery startup Marqo.ai said today it has closed on an A$8 million (about $5.2 million USD) seed funding round. The lead investor in the company, ...